At the forefront of
single cell genetic analysis

RHS Ltd is a developer of advanced single cell genomic technologies with a focus on improving health and research outcomes.

News

RHS Scheme Booklet registered with Australian Securities & Investments Commission

Second Ghent study demonstrates DOPlify™ suitability for liquid biopsy applications

RHS demonstrates advanced performance for NGS product PG-Seq™

RHS & Monash IVF Lead the Field in Non-Invasive Embryo Screening (Bioshares)

September Quarterly Business Update 2017

RHS Ltd is a developer of advanced single cell genomic technologies with a focus on improving health and research outcomes.

Learn more
about RHS

Feature Product

DOPlify™, the latest product from RHS, is an advanced whole genome amplification kit for limited DNA template

Learn More
Sign up for updates